Abvc Biopharma Inc (ABVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -270 | -1,210 | -750 | 50 | -420 |
| Depreciation Amortization | 8 | 30 | 20 | 10 | 10 |
| Other Working Capital | 30 | -380 | -440 | -440 | 90 |
| Other Operating Activity | -128 | -30 | -120 | -570 | 170 |
| Operating Cash Flow | $-360 | $-1,590 | $-1,290 | $-950 | $-150 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | 0 | -30 | -20 | 0 |
| Other Investing Activity | -10 | -30 | 0 | 0 | -1 |
| Investing Cash Flow | $-10 | $-30 | $-30 | $-20 | $-1 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 270 | 1,700 | 1,400 | 1,000 | 170 |
| Financing Cash Flow | $270 | $1,700 | $1,400 | $1,000 | $170 |
| Beginning Cash Position | 70 | 3 | 3 | 3 | 3 |
| End Cash Position | 30 | 70 | 70 | 20 | 20 |
| Net Cash Flow | $-40 | $60 | $70 | $20 | $10 |
| Free Cash Flow | |||||
| Operating Cash Flow | -360 | -1,590 | -1,290 | -950 | -150 |
| Free Cash Flow | -360 | -1,590 | -1,290 | -950 | -150 |